Antibody response linked with rejection in pediatric kidney transplant recipients
Thursday, February 28, 2013 - 20:00
in Health & Medicine
A transplanted kidney has a finite life expectancy because it often becomes the target of the recipient's immune system, which may mount antibodies that attack the organ. Because there is a critical need to extend the life of transplanted organs -- especially in children, who can face two to three kidney transplants in their lifetime -- researchers recently examined the role of this antibody-mediated injury in rejection and the effectiveness of medications to prevent it.